FDA approves Kisunla for early Alzheimer's treatment amid cognitive decline slowdown
Eli Lilly has finally achieved FDA approval for its monoclonal antibody Alzheimer’s therapy donanemab, bringing new competition to the field for Eisai and Biogen.
Archives for July 4, 2024
Ones to watch - five upcoming companies on the CAR-T scene
CAR-T therapies have big potential to take on blood cancer but also have major drawbacks.
ReciBioPharm’s Edita Botonjic-Sehic, on analytics, AI, and continuous RNA manufacturing
RNA therapeutics have emerged as a transformative approach to treating many conditions, but the industry still typically relies on inefficient batch manufacturing methods.